DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Busse W, Spector S, Rosén K, Wang Y, Alpan O.
High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects.
J Allergy Clin Immunol 2013;
132 (02) 485-486.e11
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.